Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Antibody Library Technology is a method of producing engineered as well as humanized antibodies, with the help of this technique, a greater number of antibodies could be produced by using the PCR in heavy and light chain of the antibody, these antibodies are ligated into appropriate vector to express the randomized antibody library. With the help of antibody library technology, more diverse range of antibodies can be produced by in vitro method and with technological advancement more target-based antibodies can be produced also the display technology of antibody library technology can reduce the various complexity which makes antibody library technology more popular.
Globally, the market for Antibody Library Technology Market is growing at a rapid pace owing to various reasons and the key factor which is driving the demand for antibody library technology is the increased need for highly targeted therapies to treat various serious disease such as cancer, and other diseases which majorly includes inflammatory, infectious and other immune diseases and use of antibody library technology has been proven as very effective for such diseases which is why these antibodies are widely demanded. Also, this technology is very effective in treating the neurological diseases and with rising awareness about prevalence about chronic diseases has increased the demand of antibody library technology.
COVID-19 pandemic has made a significant impact on nearly every market and it has affected the antibody library technology market as well. In most of the part of world, the lockdown was imposed in order to restrain the spread of corona virus, due to which the supply of raw material got hampered and the growth of market for antibody library technology also got hampered. However, many of the development in the health sector took place during covid crisis in most of the part of the globe which is likely to support the growth of antibody library technology.
In various parts of the globe, antibody library technology market is investigated based technology, application and end-users and geography.
The Antibody Library Technology Market finds study based on technology consists of phage display, ribosome display, yeast display and mammalian cell surface display. Based on technology, yeast and phage display hold the major share in the market owing to various reasons such as yeast surface display is a powerful method for isolating and engineering antibodies to increase their affinity and stability, while phage display is considered to versatile in vitro selection technology which is used to discover high affinity which is why phage display is highly preferred.
The Antibody Library Technology Market finds study based on end users consists of biopharmaceuticals companies, contract research organization, and academic & research institutes. Among all the end users, biopharmaceutical companies hold the major share in the market, since these companies use the antibody library technology in various therapeutic treatments, apart from that academic & research institutes spent a good amount on the investment on the R&D of antibody technology market for treating various diseases.
The Antibody Library Technology Market finds study based on application includes research application and drug discovery & development. On the basis of application, drug discovery and development hold the major share in the market; in drug discovery and development, various experiments on antibody library technology are made for the treatment of many of the rare diseases which includes cancer and HIV as well which is why these sector uses the antibody library technology the most.
Geographically, this market is studied for the major countries of North America, Europe and Asia-Pacific and rest of the world. North America is considered to be one of the very crucial markets for the antibody library technology owing to the advanced technology here, and a huge investment spent of the health care industry of the North America, apart from that various step taken by regulatory bodies in Europe region to support the growth of bio-medical sector is likely to support the growth of antibody library technology. Asia-Pacific is the fastest emerging region for antibody library technology market owing to the growing health care industry, and advanced bio-medical sector in major countries of this region which why the market for antibody library technology is growing rapidly in this sector.
Some of the major players operating in this market are AnaptysBio, Inc., MorphoSys AG, XOMA Corporation, Abzena Plc., AvantGen Inc., Adimab LLC, AbCheck s.r.o., Philogen S.p. A., Creative-Biolabs, Invenra Inc., Abgent Inc., and AxioMx Inc. among others.
February 2021: RxCelerate, a leading international out-sourced drug discovery and development platform announced to launch a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies.
December 2019: Charles River Laboratories International, Inc announced to provide new Cosmic antibody library launched by Distribution Bio, Inc. This library leads with highly attractive profiles including nano- to picomolar potency, high expression levels, thermostability, non-immunogenicity, and soluble, aggregation-resistant features. Samples to help researchers gain new insights into cardiovascular and neurological diseases.
November 2019: AvantGen announced a strategic collaboration agreement to develop Novel Anti-Cancer Therapeutic with multiple novel bi-specific NK Cell engaging therapeutic
The global Antibody Library Technology Market is studied for segments such as Technology, Application, End-users and geography. Study based on technology consists of phage display, ribosome display, yeast display and mammalian cell surface display. Based on application the market consists of research application, drug discovery & development, based on end-users the market includes. Geographically, this market is studied for the major countries of North America, Europe, Asia-pacific and rest of the world. This report also focuses upon the global trends which support the Antibody Library Technology Market.
Why to Buy This Report
